Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin in Chinese Adults with Overweight or Obesity
NCT03720574Phase 3Terminated
- Start
- Sep 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lorcaserin in obesity, Overweight. Started Sep 2019; status: terminated.
02
Drugs
lorcaserin
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT03720574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03720574.